Floatz logo

FLUOROURACILUM

Rectal Adenocarcinoma

Sixth Affiliated Hospital, Sun Yat-sen UniversitySmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Rectal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Capecitabine
Chongqing University Cancer Hospital
Phase 3B
METRONIDAZOLE
AC Camargo Cancer Center
Phase 4B
Pucotenlimab
Sun Yat-sen University
Phase 3B

View all 45 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →